gvtcx

Thrombotic Thrombocytopenic Purpura (TTP)

NHS England - Specialised Commissioning Published 8 Feb 2021 Find a Tender

key details

Statuscomplete
Category (CPV) 85000000 +1 more
RegionSouth East, London, North West
Procedurelimited
OCIDocds-h6vhtk-029113

Awards (2)

This procurement was awarded to 2 suppliers. Values shown are per-award; the notice total is ·.

description

Thrombotic Thrombocytopenic Purpura (TTP) is a serious blood disorder that results in blood clots forming in small blood vessels throughout the body. It affects the kidneys, heart and brain. If a patient is treated outside a specialist centre, mortality is 50%; in a specialist centre, it is 20%. There is also an appreciable acute morbidity, particularly in neurological disorders.

The condition can be difficult to diagnose because initial presentation can be non-specific. Rapid treatment is essential for optimal outcomes and includes plasma exchange and a range of drugs. This disease primarily affects adults. Children are treated in paediatric haematology centres and are outside the scope of this process.

notice history

1 notice published against this procurement.

PublishedTypeRegimeNotice
8 Feb 2021 Voluntary ex-ante transparency (F15) Earlier regulations 002476-2021

more from NHS England - Specialised Commissioning

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Find a Tender. Contact details for named individuals are not reproduced on this site.